Understanding the TB Market
To optimize the development and introduction of new TB products, it’s important to thoroughly understand the market. TB Alliance has investigated key characteristics of health systems to ensure products in development are in line with local needs and realities and is tackling some of the major questions and issues that could help ensure new regimens have their maximum impact on the pandemic.
A major historical challenge in tackling childhood TB has been understanding the scope of the problem.Learn More
Pathway to Patients: Charting the Dynamics of the Global TB Drug Market, was the first comprehensive analysis of how today's TB drugs reach patients on a global scale.Learn More
TB Alliance sought opinions on attributes that key decision-makers want in new regimens, including safety, efficacy, drug delivery, side effect profiles, and cost.Learn More
TB Alliance investigated health systems to understand the regimen change process, in order to accelerate and maximize the uptake of new products.Learn More
TB treatment is widely understood to be a public sector responsibility. However, our research found that in some countries the volume of TB drugs sold in the private sector is equal to or greater than the volume sold in the public sector.Learn More